Cargando…

Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome

Detalles Bibliográficos
Autores principales:	Raterman, Hennie G, Voskuyl, Alexandre E, Dijkmans, Ben AC, Nurmohamed, Michael T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787303/ https://www.ncbi.nlm.nih.gov/pubmed/19804614 http://dx.doi.org/10.1186/ar2805

Ejemplares similares

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012)

Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome - authors' response
por: Toms, Tracey E, et al.
Publicado: (2009)

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
por: van Halm, Vokko P, et al.
Publicado: (2006)

Are biologics more effective than classical disease-modifying antirheumatic drugs?
por: Nurmohamed, Michael T, et al.
Publicado: (2008)

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus
por: van den Oever, Inge A. M., et al.
Publicado: (2010)

Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus
por: Bultink, Irene EM, et al.
Publicado: (2006)

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
por: Bruijnen, Stefan, et al.
Publicado: (2016)

Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
por: Raterman, Hennie G., et al.
Publicado: (2019)

Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
por: Cahn, Rachel Tallman, et al.
Publicado: (2023)

Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: van Sijl, Alper M., et al.
Publicado: (2014)

Differential effects of leflunomide and methotrexate on cytokine production in RA
por: Kraan, MC, et al.
Publicado: (2003)

Serum methotrexate in childhood ALL.
por: Cosolo, W., et al.
Publicado: (1992)

Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
por: Overbeek, Maria J, et al.
Publicado: (2011)

Common mechanisms and holistic care in atherosclerosis and osteoporosis
por: Szekanecz, Zoltán, et al.
Publicado: (2019)

Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
por: Elbers, Laura P. B., et al.
Publicado: (2021)

Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity
por: van Eijk, Izhar C., et al.
Publicado: (2011)

Loeffler's Syndrome Secondary to Hyperinfection by Strongyloides stercoralis Associated with Methotrexate in a Patient with Rheumatoid Arthritis
por: Al Hadidi, Moayad, et al.
Publicado: (2018)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
por: Bilocca, David, et al.
Publicado: (2017)

Decrease of the plasmatic endocan cleavage ratio is associated with the hyperinflammatory phenotype of acute respiratory distress syndrome
por: Gaudet, Alexandre, et al.
Publicado: (2019)

Mitral valve disease in ankylosing spondylitis: an autoimmune disease manifestation? A case report
por: El Mathari, Sulayman, et al.
Publicado: (2022)

Etanercept plus methotrexate: An effective combination therapy for recalcitrant pemphigus vulgaris
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2015)

Nail psoriasis treated with intralesional methotrexate infiltration
por: Duarte, Artur Antônio, et al.
Publicado: (2019)

Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study
por: Bruijnen, Stefan TG, et al.
Publicado: (2012)

Prevalence of metabolic syndrome in adolescents: Reason to worry
por: Angurana, Suresh Kumar, et al.
Publicado: (2013)

Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
por: Dervieux, Thierry, et al.
Publicado: (2019)

Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
por: Bartelds, Geertje M, et al.
Publicado: (2010)

A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
por: van de Meeberg, Maartje M., et al.
Publicado: (2022)

The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
por: Tam, Huynh Thi Xuan, et al.
Publicado: (2022)

Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis
por: van Weely, Salima FE, et al.
Publicado: (2012)

Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011)

Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study
por: Overbeek, Maria J, et al.
Publicado: (2008)

Methotrexate-induced mucositis with extra-mucosal involvement after acidental overdose
por: Rampon, Greice, et al.
Publicado: (2018)

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
por: Muller, Ittai B, et al.
Publicado: (2020)

Refractory Atopic Dermatitis in Childhood: Improvement with Methotrexate?
por: Park, Young Woon, et al.
Publicado: (2013)

Subacute quadriplegic myelopathy following intrathecal methotrexate
por: Maramattom, Boby Varkey, et al.
Publicado: (2016)

Treatment of Kimura's disease with oral corticosteroid and methotrexate()()
por: Ma, Han
Publicado: (2020)

Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
por: Toms, Tracey E, et al.
Publicado: (2009)

Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis
por: Świerkot, Jerzy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d00erb6dk08emap8sf00707phc